14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.87 $1.65 Monday, 22nd Apr 2024 ADAP stock ended at $1.01. This is 3.41% more than the trading day before Friday, 19th Apr 2024. During the day the stock fluctuated 13.34% from a day low at $0.95 to a day high of $1.08.
90 days $0.691 $2.05
52 weeks $0.420 $2.05

Historical Adaptimmune Therapeutics plc prices

Date Open High Low Close Volume
Jun 02, 2021 $4.85 $4.90 $4.75 $4.79 537 452
Jun 01, 2021 $5.04 $5.04 $4.72 $4.82 1 404 047
May 28, 2021 $4.94 $5.05 $4.73 $5.03 1 618 741
May 27, 2021 $5.02 $5.07 $4.91 $5.05 433 988
May 26, 2021 $4.84 $5.07 $4.81 $4.98 578 317
May 25, 2021 $4.95 $5.04 $4.77 $4.83 668 739
May 24, 2021 $5.17 $5.17 $4.89 $4.92 680 245
May 21, 2021 $5.13 $5.37 $5.06 $5.09 2 353 284
May 20, 2021 $5.38 $5.58 $5.02 $5.12 3 583 103
May 19, 2021 $5.00 $5.13 $4.88 $4.90 705 292
May 18, 2021 $5.06 $5.27 $4.92 $5.12 1 020 890
May 17, 2021 $4.80 $4.99 $4.79 $4.93 714 976
May 14, 2021 $4.56 $4.85 $4.56 $4.82 424 835
May 13, 2021 $4.91 $4.98 $4.45 $4.56 698 101
May 12, 2021 $4.69 $4.92 $4.69 $4.84 970 595
May 11, 2021 $4.58 $4.88 $4.56 $4.78 676 072
May 10, 2021 $5.00 $5.00 $4.69 $4.72 621 002
May 07, 2021 $4.98 $5.08 $4.63 $4.78 1 227 250
May 06, 2021 $5.20 $5.23 $4.75 $4.90 1 145 792
May 05, 2021 $5.38 $5.40 $5.05 $5.12 745 490
May 04, 2021 $5.62 $5.65 $5.25 $5.35 661 285
May 03, 2021 $5.70 $5.80 $5.45 $5.68 491 097
Apr 30, 2021 $5.84 $5.97 $5.65 $5.66 723 825
Apr 29, 2021 $5.78 $5.93 $5.61 $5.78 541 093
Apr 28, 2021 $5.67 $5.78 $5.56 $5.74 1 210 894
Click to get the best stock tips daily for free!

About Adaptimmune Therapeutics plc

Adaptimmune Therapeutics plc Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4 that is in phase II clinical trials with SPEARHEAD-1 for synovial sarcoma and myxoid round cell liposa... ADAP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT